Norwood Medical LLC (Dayton) and ENGIE Resources LLC, a subsidiary of ENGIE North America (ENGIE), announce a five-year renewable energy contract. The agreement brings renewable wind energy from ENGIE ...

A police investigation is underway after a woman was found shot inside a vehicle in Milton, Massachusetts, on Thursday ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Moderna fell to a new 52-week low after some disappointing news. The short explanation is that demand for Moderna's COVID-19 vaccine has plunged since the end of the pandemic. Moderna still has ...

Part of a historic home has collapsed due to an early morning fire in Norwood.Crews were dispatched to Floral and Hudson Avenues Thursday morning for a house fire.Flames could be seen throughout ...

Moderna has lowered 2025 revenue guidance after a tough 2024 coronavirus vaccination season. However, the company aims to launch 10 new products over the next few years -- and that could lead to ...

CINCINNATI — A massive fire had crews trying to save a Norwood historic house on Thursday. Crews at the scene said they received reports of a house fire, around 3 a.m., on the corner of Floral ...

Don’t call her ma’am. Lara Spencer jokingly scolded “The Night Agent” star Gabriel Basso for the one-word title he gave her during their interview on “Good Morning America” Wednesday.

Ratings for Moderna MRNA were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings ...

Have you received a text lately accusing you of owing unpaid toll bills? Beware: texts are part of the latest “smishing” scam, according to the Massachusetts Department of Transportation ...

A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). The messenger RNA (mRNA) pioneer provided a business and pipeline update at the J.P. Morgan Healthcare Conference on Monday.